To investigate how HDCA suppresses CRC growth, we examined its impact on FXR and TGR5 receptors, ultimately determining that HDCA curbs CRC proliferation via FXR activation, not TGR5. Here, GPBAR1 is linked to pancreatic hypoplasia-diabetes-congenital heart disease syndrome.